查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2011852

一次性生物製程市場：2026-2032年全球市場預測（按產品、工作流程階段、生物製程方法、一次性子組件、製造流程、應用和最終用戶分類）

Single-use Bioprocessing Market by Offering, Workflow Stage, Bioprocess Mode, Single-use Subassemblies, Manufacturing Processes, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，一次性生物製程市場價值將達到 208.1 億美元，到 2026 年將成長至 241.1 億美元，到 2032 年將達到 597.7 億美元，年複合成長率為 16.26%。

主要市場統計數據
基準年 2025 208.1億美元
預計年份：2026年 241.1億美元
預測年份 2032 597.7億美元
複合年成長率 (%) 16.26%

概述影響全球生物製造領導者策略決策的一次性生物製程技術和市場動態。

一次性生物製程已從實驗性方法發展成為生物製藥研發和商業化生產的核心製造模式。近年來，技術的進步、一次性技術的監管核准以及營運重點的轉變，都提高了研發人員、合約服務供應商和大型製藥企業對一次性製程的興趣。本文說明了一次性系統如今的重要性：它們可以降低交叉污染的風險，縮短宣傳活動週期，並提供模組化設計以支援靈活的生產結構。

數位整合、模組化設計和永續性舉措：正在重塑一次性生物製程。

一次性生物製程領域正經歷著一場變革性的轉型，其驅動力來自技術、監管和商業性等多面向因素。材料科學的進步和感測器的微型化提高了一次性組件的可靠性和分析能力，從而實現了更精確的製程控制和可重複的結果。同時，連接性的提升、嵌入式探針的引入以及透過遠端監控實現的數位化整合，使得一次性系統能夠與現代自動化框架相容，降低了其在受監管生產環境中的准入門檻。

對 2025 年美國預期關稅措施將如何影響一次性生物加工的整個供應鏈、籌資策略和成本結構進行全面評估。

美國預計將於2025年實施的關稅措施和貿易政策調整可能會影響籌資策略和庫存管理，並對一次性產品的整個供應鏈產生連鎖反應，但不會改變一次性產品的基本價值提案。關稅帶來的成本壓力可能促使製造商重新評估其供應商多元化策略，盡可能優先考慮國內採購，並協商簽訂更長期的供應合約以降低價格波動。這些調整可能會影響前置作業時間，並促使企業更加重視對二級供應商進行認證，以確保供應的連續性。

詳細的細分分析揭示了產品、工作流程、應用程式和最終用戶之間的差異，從而確定採購、部署和創新重點。

了解需求和部署模式需要採用精細化的細分方法，將產品、工作流程、應用和最終用戶與採購和技術優先順序相匹配。從產品角度來看，生物反應器、層析法系統、過濾系統以及混合、儲存和填充系統等設備和工廠是資本投資和整合規劃的核心。生物反應器的容量選擇，從 1000 公升到 1001 公升、2000 公升，甚至更大，都會影響製程設計和供應鏈的複雜性。除了諸如袋子、探針和感測器以及採樣系統等簡單和周邊元件外，管道、過濾器、連接器和傳輸系統對於運行可靠性也至關重要，其中探針和感測器涵蓋電導率、流速、氧氣、pH 值、壓力和溫度的測量。細胞培養系統和注射器等運作設備類別有其自身的採購週期和驗證路徑，這些流程與設施設計選擇密切相關。

從美洲、歐洲、中東和非洲以及亞太地區，詳細分析了採用趨勢、法規環境和產能趨勢的區域觀點。

區域趨勢對產品應用、監管和供應鏈設計的影響方式截然不同，這要求企業主管根據每個地理叢集的具體情況調整策略。在美洲，強大的契約製造網路、成熟的法規結構以及生物技術叢集的集中，正推動一次性產品在臨床和商業生產中的快速普及。北美企業往往優先考慮快速的臨床部署和與供應商的整合關係，更傾向於選擇能夠提供承包系統和驗證支援的供應商。

全面概述競爭格局，重點在於推動創新、夥伴關係和產業重組的關鍵製造商、系統整合商和服務供應商。

一次性生物製程領域的競爭格局呈現出持續性，涵蓋了從專業元件供應商到全方位系統整合商和服務供應商的各個環節。領先的儀器製造商持續投資於穩健的拋棄式平台，不斷擴展感測器和分析功能，以滿足對製程可視性和法規遵循的需求。同時，越來越多的利基供應商專注於高性能耗材，例如一次性過濾、專用連接器和先進的管路材料。這些公司憑藉技術差異化和與現有系統的兼容性檢驗競爭。

為行業領導者提供切實可行的策略建議，以最佳化其供應鏈、加快採用速度並調整其經營模式，以適應不斷變化的一次性使用趨勢。

領導企業應採取平衡策略，既保持柔軟性，又確保供應連續性，同時使技術選擇與監管要求相符。這首先需要建立一個跨職能的管治結構，整合採購、品質、工程和營運部門，並對一次性部署決策進行全面評估。此管治結構應明確供應商認證標準、變更管理觸發機制以及關鍵零件的緊急時應對計畫，以降低意外中斷的風險。

方法論概述，解釋了支持本報告研究結果的主要和次要研究方法、檢驗方法和分析框架。

本研究採用綜合分析方法，結合一手訪談、供應商和最終使用者畫像以及嚴謹的二手資訊檢驗，確保分析結果反映實際情況。一手研究包括與來自不同組織的技術負責人、採購負責人和營運經理進行結構化討論，以了解影響一次性部署的決策因素、挑戰和實際應對措施。基於這些直接洞察，我們針對技術成熟度、供應鏈韌性和監管考量進行了主題分析。

在不斷發展的單次使用生物製程系統中，策略挑戰和營運經驗的果斷整合將指導經營團隊決策。

總之，經營團隊面臨的挑戰顯而易見。一次性生物製程是一種極具吸引力的解決方案，它兼具操作柔軟性、污染控制和模組化擴充性，但嚴格的供應商管治和系統化的規劃對於充分發揮其潛力至關重要。成功實施此流程的公司透過結合技術評估、策略供應商合作和完善的驗證體系，使其製程設計選擇與監管要求和業務目標保持一致。結論部分總結了本報告的關鍵主題，並重點強調了為最有效地降低風險和加速實現效益而應優先採取的行動。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 一次性生物製程市場：依產品/服務分類

  • 各個部件
    • 袋子和容器
    • 連接器
    • 過濾和分離設備
    • 泵浦和流量控制
    • 採樣裝置及配件
    • 感測器和探頭
    • 管子
      • 聚乙烯（PE）
      • 聚丙烯（PP）
      • 聚氯乙烯（PVC）
      • 矽酮
  • 一次性子組件
    • 生物反應器/製程組件
    • 培養基轉移組件
    • 採樣組件
    • 管路組件/歧管

第9章：一次性生物製程市場：各階段工作流程

  • 下游工藝
  • 填充和表面處理工程
  • 品管/分析
  • 上游工程

第10章：以生物製程方法分類的一次性生物製程市場

  • 批次
  • 聯邦批次
  • 灌注

第11章 一次性生物製程市場（以一次性子組件分類）

  • 無菌轉移套裝
  • 填充子組件
  • 歧管組件
  • 取樣子組件
  • 管組件

第12章 按製造流程分類的一次性生物製程市場

  • 3D列印
  • 黏附
  • 吹塑成型
  • 擠壓
  • 射出成型
  • 包覆成型
  • 高頻焊接
  • 熱成型
  • 超音波焊接

第13章 一次性生物製程市場：依應用領域分類

  • 無菌灌裝
  • 細胞培養
  • 過濾
  • 混合物
  • 純化
  • 取樣
  • 貯存

第14章 一次性生物製程市場：依最終用戶分類

  • 學術和研究機構
  • 契約製造組織（CMO）和受託研究機構（CRO）
  • 製藥和生物技術公司

第15章 一次性生物製程市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 一次性生物製程市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 一次性生物製程市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國一次性生物製程市場

第19章：中國一次性生物製程市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AdvantaPure by NewAge Industries
  • Agilitech
  • Aseptic Group
  • Avantor, Inc.
  • Bionet Servicios Tecnicos SL
  • BioPharma Dynamics Ltd.
  • CellBios Healthcare & Lifesciences Pvt. Ltd.
  • Compagnie de Saint-Gobain
  • Corning Incorporated
  • Cytiva by Danaher Corporation
  • Entegris, Inc.
  • Eppendorf SE
  • Foxx Life Sciences
  • Freudenberg Group
  • Getinge AB
  • Kuehne+Nagel International AG
  • Lonza Group AG Ltd.
  • Meissner Corporation
  • Merck KGaA
  • Mettler-Toledo International Inc.
  • Parker-Hannifin Corporation
  • PBS Biotech, Inc.
  • PharmNXT Biotech
  • PSG Dover by Dover Corporation
  • Repligen Corporation
  • SaniSure
  • Sartorius AG
  • Satake Multimix Corporation
  • Single Use Support GmbH
  • Tekni-Plex, Inc.
  • Thermo Fisher Scientific Inc.
  • Watson-Marlow Fluid Technology Solutions by Spirax Group PLC
Product Code: MRR-431752EA4978

The Single-use Bioprocessing Market was valued at USD 20.81 billion in 2025 and is projected to grow to USD 24.11 billion in 2026, with a CAGR of 16.26%, reaching USD 59.77 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 20.81 billion
Estimated Year [2026] USD 24.11 billion
Forecast Year [2032] USD 59.77 billion
CAGR (%) 16.26%

Executive introduction to single-use bioprocessing technologies and market dynamics that frame strategic decisions for biomanufacturing leaders worldwide

Single-use bioprocessing has matured from an experimental approach into a core manufacturing paradigm for biologics development and commercial production. Over recent years, technological refinements, regulatory acceptance of disposable technologies, and shifting operational priorities have accelerated interest across developers, contract service providers, and established pharmaceutical manufacturers. This introduction outlines the context for why disposable systems matter now: they reduce cross-contamination risk, enable faster campaign turnaround, and offer modularity that supports flexible manufacturing footprints.

As organizations balance the need for speed with stringent quality controls, single-use solutions present trade-offs that require careful evaluation. Capital planning, material supply reliability, and integration with existing stainless-steel assets present practical considerations that shape implementation timelines. The introduction also previews themes that recur throughout the analysis, including lifecycle sustainability, digital instrumentation and sensors, fill-finish decentralization, and the evolving role of suppliers as system integrators rather than component vendors.

Readers will find that appreciating the technology not only in isolation but as part of a broader biomanufacturing ecosystem clarifies where value accrues and where risks remain. Subsequent sections build on this foundation by examining the transformative shifts driving adoption, the implications of changing trade policy, the nuanced segmentation of demand, and the regional and competitive dynamics executives must weigh when defining their single-use strategies.

Emerging technological and operational inflection points reshaping single-use bioprocessing including digital integration, modular design, and sustainability drivers

The single-use bioprocessing landscape is undergoing transformative shifts driven by converging technological, regulatory, and commercial forces. Advances in materials science and sensor miniaturization have improved the reliability and analytics available within disposable assemblies, enabling closer process control and more reproducible outcomes. At the same time, digital integration-through improved connectivity, embedded probes, and remote monitoring-has made single-use systems compatible with modern automation frameworks, thus lowering the barrier to deployment in regulated production environments.

Operational models are also shifting. Manufacturers increasingly prefer modular, skidded solutions that can be scaled horizontally to meet variable demand rather than investing in large fixed-capacity stainless-steel facilities. This change supports fast product lifecycle transitions and contract manufacturing arrangements where rapid changeover and near-term flexibility matter most. Sustainability concerns and lifecycle assessment methodologies are placing new emphasis on material reuse where feasible, while also recognizing the energy and water savings that disposables can deliver over certain process footprints.

Moreover, supply chain resilience has moved to the top of procurement agendas. The industry is responding with supplier consolidation in some segments and with deeper partnerships in others, where vendors provide integrated systems, validation support, and inventory management services. These shifts create an imperative for biomanufacturers to reassess vendor selection criteria, governance models for technology transfer, and investment priorities that balance short-term agility with long-term operational continuity.

Comprehensive assessment of how United States tariff measures anticipated in 2025 could affect supply chains, sourcing strategies, and cost structures across single-use bioprocessing

Anticipated tariff actions and trade policy adjustments in the United States for 2025 have the potential to reverberate through single-use supply chains, influencing sourcing strategies and inventory management without altering the underlying value proposition of disposables. Tariff-driven cost pressures can prompt manufacturers to revisit their vendor diversification strategies, prioritize domestic sourcing options where feasible, and negotiate longer-term supply agreements to smooth price volatility. These adjustments, in turn, can alter lead times and increase emphasis on qualification of secondary suppliers to preserve continuity.

Importantly, companies may respond by adapting procurement tactics: increasing local inventory buffers for critical components, shifting to suppliers with regional manufacturing footprints, or revising contracts to include price adjustment mechanisms tied to trade measures. Such tactical responses help reduce exposure but can increase working capital requirements and complicate logistics. Strategic responses can include investing in local assembly capability for critical subassemblies or deepening partnerships with suppliers who can provide dual-sourcing assurances and validated equivalents for proprietary materials.

Regulatory and compliance considerations also intersect with tariff responses. When sourcing shifts across borders, companies must ensure that material traceability, certificate of analysis requirements, and change control procedures remain robust. Firms that proactively align their supply chain governance with expected policy scenarios will maintain higher operational resilience and reduce the risk of production disruption. Ultimately, while tariffs influence cost structures and sourcing choices, the most successful organizations will treat trade measures as one variable within a broader resilience and supplier management strategy.

Deep segmentation intelligence revealing product, workflow, application, and end-user distinctions that determine procurement, deployment, and innovation priorities

Understanding demand and deployment patterns requires a nuanced segmentation approach that aligns products, workflows, applications, and end users with procurement and technical priorities. From a product perspective, apparatus and plants including bioreactors, chromatography systems, filtration systems, mixing, storage, and filling systems occupy the core of capital and integration planning; bioreactor sizing choices from up to 1000L through 1001L to 2000L and above 2000L influence process design and supply chain complexity. Simple and peripheral elements such as bags, probes and sensors, sampling systems, along with tubing, filters, connectors, and transfer systems are essential to operational reliability, with probes and sensors covering conductivity, flow, oxygen, pH, pressure, and temperature measurement. Work equipment categories such as cell culture systems and syringes present their own procurement cycles and validation pathways that intersect with facility design choices.

When viewed through the lens of workflow stage, distinctions between upstream processing, downstream processing, fill-finish operations, and quality control and analytics determine how organizations allocate capital and technical resources. Upstream decisions often drive requirements for containment, sterility, and sensor integration, while downstream choices emphasize purification capacity and single-use chromatography and filtration consumables. Fill-finish operations necessitate robust aseptic strategies and equipment compatibility with closed-system disposables, and quality control workflows require validated sampling, analytics, and traceability to meet regulatory expectations.

Application-driven segmentation further refines priorities: aseptic filling, cell culture growth, filtration, mixing, purification, sampling, and storage each impose distinct demands on materials, compatibility testing, and operator training. End users, ranging from academic and research institutes to contract manufacturing and research organizations, as well as pharmaceutical and biotechnology companies, approach adoption with differing risk profiles, validation capabilities, and budgetary constraints. Together, these segmentation axes reveal where suppliers should focus product development, how integrators should configure systems, and why purchasers must balance technical fit, regulatory readiness, and service commitments when selecting single-use solutions.

Granular regional perspectives on adoption trajectories, regulatory environments, and capacity trends across the Americas, Europe, Middle East & Africa, and Asia-Pacific

Regional dynamics shape adoption, regulation, and supply chain design in materially different ways, requiring executives to tailor strategies for each geographic cluster. In the Americas, strong contract manufacturing networks, a mature regulatory framework, and a concentration of biotech clusters drive rapid adoption of disposables for both clinical and commercial manufacturing. North American organizations tend to emphasize speed to clinic and integrated supplier relationships, which favors vendors offering turnkey systems and validation support.

Europe, Middle East & Africa presents a complex regulatory mosaic and a high focus on sustainability and lifecycle assessment. Regulatory stringency combined with heightened attention to environmental impact pushes stakeholders to evaluate trade-offs between disposables and reusable systems, often prompting hybrid approaches that pair disposables with centralized utilities and waste management strategies. The region also demonstrates active public-private initiatives to bolster manufacturing resilience and to expand local capability in advanced therapies.

Asia-Pacific exhibits diverse adoption patterns driven by rapid capacity expansion, government-supported biomanufacturing initiatives, and a growing base of contract manufacturers. Increasing investment into local production and the desire to shorten supply chains encourage partnerships with suppliers capable of regional manufacturing or local assembly to meet throughput and qualification timelines. Across all regions, regulatory harmonization efforts and cross-border supply chain planning remain pivotal to scaling single-use deployments efficiently.

Competitive landscape synthesis highlighting leading manufacturers, system integrators, and service providers driving innovation, partnerships, and consolidation dynamics

Competitive dynamics in single-use bioprocessing reflect a continuum from specialized component suppliers to full-scope systems integrators and service providers. Leading equipment manufacturers continue to invest in robust disposable platforms while expanding sensor and analytics capabilities to meet demand for process visibility and regulatory compliance. At the same time, a growing number of niche suppliers focus on high-performance consumables such as single-use filtration media, specialized connectors, and advanced tubing materials; these firms compete on technical differentiation and validated compatibility with legacy systems.

Service providers and contract organizations increasingly participate in the value chain by offering validation support, inventory management, and assembly services that reduce purchaser burden. This trend blurs traditional supplier-customer boundaries as companies seek bundled offerings that include installation, training, and lifecycle support. Partnerships and strategic alliances are common, with technology cross-licensing and co-development agreements accelerating time-to-market for integrated solutions.

The fastest-moving companies combine engineering excellence with an ability to support regulatory submissions and supply continuity. Firms that can demonstrate rigorous quality systems, documented traceability, and robust after-sales service establish durable commercial relationships. For purchasers, assessing supplier capability now requires evaluating not only product performance but also the supplier's global footprint, validation toolkits, and readiness to support multi-site deployments over extended product lifecycles.

Actionable strategic recommendations for industry leaders to optimize supply chains, accelerate adoption, and align commercial models with evolving single-use dynamics

Leaders should pursue a balanced approach that preserves flexibility, ensures supply continuity, and aligns technical choices with regulatory obligations. Begin by establishing cross-functional governance that brings together procurement, quality, engineering, and operations to evaluate single-use adoption decisions holistically. This governance should codify supplier qualification criteria, change-control triggers, and contingency plans for critical components to reduce the risk of unexpected disruptions.

Next, prioritize dual-sourcing and regional supplier relationships where feasible to mitigate trade and logistic exposures while negotiating long-term commitments that include service-level expectations and validation artifacts. Invest in internal capabilities for integration and qualification so that partner handoffs do not become bottlenecks; organizations that develop in-house expertise in single-use assembly, cleaning of shared utilities, and analytics will shorten deployment cycles and reduce external dependency.

Finally, integrate sustainability and lifecycle analysis into procurement decisions to identify where disposables demonstrably reduce energy, water, or contamination risk, and where hybrid models provide the best total impact. Encourage suppliers to provide detailed material declarations and end-of-life handling programs, and embed those considerations into capital planning and vendor scorecards to drive continuous improvement across the supply base.

Methodological overview explaining primary and secondary research approaches, validation techniques, and analytical frameworks that underpin the report's findings

The research synthesis relies on a mixed-methods approach combining primary interviews, supplier and end-user profiling, and rigorous secondary-source validation to ensure the analysis reflects operational realities. Primary research involved structured discussions with technical leaders, procurement heads, and operations managers across a range of organizations to capture decision drivers, pain points, and practical workarounds that influence single-use adoption. These firsthand insights anchored thematic analysis around technology readiness, supply chain resilience, and regulatory considerations.

Secondary research included targeted reviews of technical literature, standards publications, and regulatory guidance documents to validate technical claims and to map common qualification pathways. Data triangulation and cross-validation steps ensured that reported trends represent broad industry sentiment rather than isolated experiences. The methodology also applied scenario analysis to examine how sourcing, tariff, and regional variables interact with operational priorities, while preserving confidentiality and anonymization for all contributing interviewees.

Quality assurance processes encompassed peer review by subject-matter experts and a final editorial pass focusing on technical accuracy and clarity. The resulting analytical framework supports decision-makers by linking strategic imperatives to operational actions and by providing a reproducible basis for internal benchmarking and supplier evaluation exercises.

Conclusive synthesis of strategic imperatives and operational takeaways to guide executive decisions in the evolving single-use bioprocessing ecosystem

In closing, the imperative for executives is clear: single-use bioprocessing presents a compelling mix of operational flexibility, contamination control, and modular scalability, yet it requires disciplined supplier governance and systemic planning to realize its potential. Successful adopters couple technological evaluation with strategic supplier engagement and robust validation frameworks, thereby aligning process design choices with regulatory and business objectives. The conclusion consolidates the report's central themes and reinforces the priority actions that will most effectively reduce risk and accelerate benefit realization.

As organizations refine their approach to single-use systems, attention to supply chain resilience, regional regulatory nuance, and integrated service offerings will distinguish leaders from followers. Executives should treat the transition to disposables as a programmatic change that spans procurement, quality, engineering, and sustainability agendas rather than a series of isolated purchases. With thoughtful planning and targeted investment in people and processes, the operational advantages of single-use technologies can be achieved while maintaining compliance, predictability, and cost discipline.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Single-use Bioprocessing Market, by Offering

  • 8.1. Individual Components
    • 8.1.1. Bags & Containers
    • 8.1.2. Connectors
    • 8.1.3. Filtration & Separation Devices
    • 8.1.4. Pumps & Flow Control
    • 8.1.5. Sampling Devices & Accessories
    • 8.1.6. Sensors & Probes
    • 8.1.7. Tubing
      • 8.1.7.1. Polyethylene (PE)
      • 8.1.7.2. Polypropylene (PP)
      • 8.1.7.3. Polyvinyl Chloride (PVC)
      • 8.1.7.4. Silicone
  • 8.2. Single-Use Subassemblies
    • 8.2.1. Bioreactor / Process Assemblies
    • 8.2.2. Media Transfer Assemblies
    • 8.2.3. Sampling Assemblies
    • 8.2.4. Tubing Assemblies / Manifolds

9. Single-use Bioprocessing Market, by Workflow Stage

  • 9.1. Downstream Processing
  • 9.2. Fill-Finish Operations
  • 9.3. Quality Control & Analytics
  • 9.4. Upstream Processing

10. Single-use Bioprocessing Market, by Bioprocess Mode

  • 10.1. Batch
  • 10.2. Fed-Batch
  • 10.3. Perfusion

11. Single-use Bioprocessing Market, by Single-use Subassemblies

  • 11.1. Aseptic Transfer Sets
  • 11.2. Filling Subassemblies
  • 11.3. Manifold Assemblies
  • 11.4. Sampling Subassemblies
  • 11.5. Tubing Assemblies

12. Single-use Bioprocessing Market, by Manufacturing Processes

  • 12.1. 3D Printing
  • 12.2. Adhesive Bonding
  • 12.3. Blow Molding
  • 12.4. Extrusion
  • 12.5. Injection Molding
  • 12.6. Overmolding
  • 12.7. RF Welding
  • 12.8. Thermoforming
  • 12.9. Ultrasonic Welding

13. Single-use Bioprocessing Market, by Application

  • 13.1. Aseptic Filling
  • 13.2. Cell Culture
  • 13.3. Filtration
  • 13.4. Mixing
  • 13.5. Purification
  • 13.6. Sampling
  • 13.7. Storage

14. Single-use Bioprocessing Market, by End User

  • 14.1. Academic & Research Institutes
  • 14.2. Contract Manufacturing Organizations & Contract Research Organizations
  • 14.3. Pharmaceutical & Biotechnology Companies

15. Single-use Bioprocessing Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Single-use Bioprocessing Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Single-use Bioprocessing Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Single-use Bioprocessing Market

19. China Single-use Bioprocessing Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. AdvantaPure by NewAge Industries
  • 20.6. Agilitech
  • 20.7. Aseptic Group
  • 20.8. Avantor, Inc.
  • 20.9. Bionet Servicios Tecnicos SL
  • 20.10. BioPharma Dynamics Ltd.
  • 20.11. CellBios Healthcare & Lifesciences Pvt. Ltd.
  • 20.12. Compagnie de Saint-Gobain
  • 20.13. Corning Incorporated
  • 20.14. Cytiva by Danaher Corporation
  • 20.15. Entegris, Inc.
  • 20.16. Eppendorf SE
  • 20.17. Foxx Life Sciences
  • 20.18. Freudenberg Group
  • 20.19. Getinge AB
  • 20.20. Kuehne + Nagel International AG
  • 20.21. Lonza Group AG Ltd.
  • 20.22. Meissner Corporation
  • 20.23. Merck KGaA
  • 20.24. Mettler-Toledo International Inc.
  • 20.25. Parker-Hannifin Corporation
  • 20.26. PBS Biotech, Inc.
  • 20.27. PharmNXT Biotech
  • 20.28. PSG Dover by Dover Corporation
  • 20.29. Repligen Corporation
  • 20.30. SaniSure
  • 20.31. Sartorius AG
  • 20.32. Satake Multimix Corporation
  • 20.33. Single Use Support GmbH
  • 20.34. Tekni-Plex, Inc.
  • 20.35. Thermo Fisher Scientific Inc.
  • 20.36. Watson-Marlow Fluid Technology Solutions by Spirax Group PLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SINGLE-USE BIOPROCESSING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SINGLE-USE BIOPROCESSING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BAGS & CONTAINERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BAGS & CONTAINERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BAGS & CONTAINERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONNECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONNECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONNECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION & SEPARATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION & SEPARATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION & SEPARATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PUMPS & FLOW CONTROL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PUMPS & FLOW CONTROL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PUMPS & FLOW CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING DEVICES & ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING DEVICES & ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING DEVICES & ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SENSORS & PROBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SENSORS & PROBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SENSORS & PROBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY POLYETHYLENE (PE), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY POLYETHYLENE (PE), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY POLYETHYLENE (PE), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY POLYPROPYLENE (PP), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY POLYPROPYLENE (PP), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY POLYPROPYLENE (PP), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY POLYVINYL CHLORIDE (PVC), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY POLYVINYL CHLORIDE (PVC), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY POLYVINYL CHLORIDE (PVC), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTOR / PROCESS ASSEMBLIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTOR / PROCESS ASSEMBLIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOREACTOR / PROCESS ASSEMBLIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MEDIA TRANSFER ASSEMBLIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MEDIA TRANSFER ASSEMBLIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MEDIA TRANSFER ASSEMBLIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING ASSEMBLIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING ASSEMBLIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING ASSEMBLIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING ASSEMBLIES / MANIFOLDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING ASSEMBLIES / MANIFOLDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING ASSEMBLIES / MANIFOLDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILL-FINISH OPERATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILL-FINISH OPERATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILL-FINISH OPERATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY QUALITY CONTROL & ANALYTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY QUALITY CONTROL & ANALYTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY QUALITY CONTROL & ANALYTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPSTREAM PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY UPSTREAM PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BATCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BATCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BATCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FED-BATCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FED-BATCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FED-BATCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PERFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PERFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PERFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ASEPTIC TRANSFER SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ASEPTIC TRANSFER SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ASEPTIC TRANSFER SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILLING SUBASSEMBLIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILLING SUBASSEMBLIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILLING SUBASSEMBLIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANIFOLD ASSEMBLIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANIFOLD ASSEMBLIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANIFOLD ASSEMBLIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING SUBASSEMBLIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING SUBASSEMBLIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING SUBASSEMBLIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING ASSEMBLIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING ASSEMBLIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING ASSEMBLIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY 3D PRINTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY 3D PRINTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY 3D PRINTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ADHESIVE BONDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ADHESIVE BONDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ADHESIVE BONDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BLOW MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BLOW MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY BLOW MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY EXTRUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY EXTRUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY EXTRUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY INJECTION MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY INJECTION MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY OVERMOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY OVERMOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY OVERMOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY RF WELDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY RF WELDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY RF WELDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY THERMOFORMING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY THERMOFORMING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY THERMOFORMING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ULTRASONIC WELDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ULTRASONIC WELDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ULTRASONIC WELDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ASEPTIC FILLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ASEPTIC FILLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ASEPTIC FILLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CELL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY FILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY MIXING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PURIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PURIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PURIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY SAMPLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 158. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 159. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 160. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 161. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 162. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 163. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 164. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 165. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 166. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. AMERICAS SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 258. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 259. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 260. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 261. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 262. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 263. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 264. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 265. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 266. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 267. GCC SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 290. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 291. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 292. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 293. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING, 2018-2032 (USD MILLION)
  • TABLE 294. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 295. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY WORKFLOW STAGE, 2018-2032 (USD MILLION)
  • TABLE 296. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY BIOPROCESS MODE, 2018-2032 (USD MILLION)
  • TABLE 297. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY SINGLE-USE SUBASSEMBLIES, 2018-2032 (USD MILLION)
  • TABLE 298. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY MANUFACTURING PROCESSES, 2018-2032 (USD MILLION)
  • TABLE 299. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 300. G7 SINGLE-USE BIOPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 301. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 302. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 303. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY INDIVIDUAL COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 304. NATO SINGLE-USE BIOPROCESSING MARKET SIZE, BY TUBING,